The cobalt–albumin binding assay: Insights into its mode of action
Authors:
- David Bar-OrDavid Bar-Or
- Leonard T. RaelLeonard T. Rael
- Raphael Bar-OrRBRaphael Bar-Or
- Denetta S. SloneDSDenetta S. Slone
- Charles W. MainsCMCharles W. Mains
- Nagaraja K.R. RaoNRNagaraja K.R. Rao
- C. Gerald CurtisCCC. Gerald Curtis
- 1 January 2008
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 387 (1-2) , 120-127
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The PRIMA Study: presentation ischaemia-modified albumin in the emergency departmentEmergency Medicine Journal, 2006
- Evaluation of effects of ischaemia on the albumin cobalt binding (ACB) assay in patients exposed to traumaEmergency Medicine Journal, 2006
- Heterogeneity and oxidation status of commercial human albumin preparations in clinical use*Critical Care Medicine, 2005
- Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndromeCanadian Medical Association Journal, 2005
- Clinical and Analytical Review of Ischemia‐Modified Albumin Measured by the Albumin Cobalt Binding Test2005
- Ischemia Modified Albumin Is a Sensitive Marker of Myocardial Ischemia After Percutaneous Coronary InterventionCirculation, 2003
- Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: A preliminary comparison to creatine kinase-MB, myoglobin, and troponin IAmerican Heart Journal, 2001
- Characterization of the Co2+ and Ni2+ binding amino‐acid residues of the N‐terminus of human albuminEuropean Journal of Biochemistry, 2001
- A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary reportThe Journal of Emergency Medicine, 2000
- Involvement of a lysine residue in the N‐terminal Ni2+ and Cu2+ binding site of serum albuminsEuropean Journal of Biochemistry, 1994